TG Therapeutics, Inc.

TGTX · NASDAQ

TG Therapeutics, Inc.TGTX · NASDAQ

Regular Market · Oct 30, 08:00 PM

$61.18+$3.10 +5.34%

After Hours $61.20 +$0.02 +0.03%

Oct 30, 08:06 PM

High: —
Low: —
Volume: —

Loading chart…

Ask Alva about TGTX

TG Therapeutics, Inc.

TGTX · Biotechnology

61.18 USD

+3.10 (+5.34%)

At Close

61.20 USD

+0.02 (+0.03%)

After hours

High
Low
Volume
Open
Prev Close
Turnover
Trailing P/E
Market Cap
Turnover Ratio
Free Float
Post-Market
VWAP
Range (%)
Volume Ratio
52-Wk High
52-Wk Low
Forward P/E
Beta

TG Therapeutics, Inc.

TGTX · NASDAQ

At Close

61.18 USD

+3.10 (+5.34%)

After hours 61.20 USD +0.02 (+0.03%)

High
Low
Volume
Open
Prev Close
Turnover
Trailing P/E
Market Cap
Turnover Ratio
Free Float
Post-Market
VWAP
Range (%)
Volume Ratio
52-Wk High
52-Wk Low
Forward P/E
Beta

Unusual Price Movement

TGTX extended its rebound alongside MS-treatment peers and healthcare stocks despite the broader selloff.

There is no new catalyst. TGTX rose about 5.8%, extending the earlier rebound as Novartis, Roche and the XLV healthcare benchmark also gained while the S&P 500 and Nasdaq fell. The peer and healthcare strength supported the move, with TGTX outperforming that group.

Unusual Price Movement

TGTX extended its rebound alongside MS-treatment peers and healthcare stocks despite the broader selloff.

Ask Alva anything. @ for context, / for skills

Ask Alva about TGTX

TGTX extended its rebound alongside MS-treatment peers and healthcare stocks despite the broader selloff. ⓘ

TGTX extended its rebound alongside MS-treatment peers and healthcare stocks despite the broader selloff. ⓘ

TGTX extended its rebound alongside MS-treatment peers and healthcare stocks despite the broader selloff.

TGTX extended its rebound alongside MS-treatment peers and healthcare stocks despite the broader selloff.